To include your compound in the COVID-19 Resource Center, submit it here.

Gliadel Wafer carmustine implant: Phase II data

An open-label, U.S. Phase II trial in 59 evaluable patients with 1-3 brain metastases

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE